{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:11:42Z","timestamp":1792782702442,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"SHOWA Medical University","id":[{"id":"https:\/\/ror.org\/04mzk4q39","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-exposure laparoscopic and endoscopic cooperative surgery (LECS), known as CLEAN-NET (combination of laparoscopic and endoscopic approaches to neoplasia with non-exposure technique), was developed for gastric submucosal tumors; however, its oncologic validity for gastric cancer remains unclear. We evaluated long-term oncologic outcomes of CLEAN-NET in patients with clinically diagnosed cT1N0 gastric cancer during the early developmental phase of this technique.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed 19 consecutive patients who underwent CLEAN-NET between December 2008 and June 2010. Treatment selection was based on preoperative clinical staging available at that time. Limited regional lymph node assessment was performed in selected cases, and pathological findings were classified according to the eCura system. Recurrence of the gastric cancer treated by CLEAN-NET, metachronous gastric cancer, overall survival, and causes of death were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median follow-up period was 6.2\u00a0years, with follow-up extending up to 16.8\u00a0years. Although treatment selection was based on preoperative cT1N0 assessment, 14 patients (73.7%) were subsequently classified as eCuraC-2 because of postoperative pathological risk factors. Limited regional lymph node dissection was performed in 15 patients, and pathological lymph node metastasis was identified in 1 patient. Additional surgery was performed in 3 patients. No recurrence of the gastric cancer treated by CLEAN-NET was observed. Metachronous gastric cancer developed in the preserved stomach in 2 patients, including 1 death from metachronous gastric cancer. During follow-up, 3 patients died: 1 from lung cancer, 1 from metachronous gastric cancer, and 1 from pneumonia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This historical cohort provides rare ultra-long-term observational data after CLEAN-NET for gastric cancer. Although no recurrence of the gastric cancer treated by CLEAN-NET was observed, the findings do not establish CLEAN-NET as an alternative to guideline-recommended gastrectomy. Rather, they may inform future studies of function-preserving, non-exposure local resection combined with validated nodal navigation strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00464-026-13139-z","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T19:37:06Z","timestamp":1784057826000},"page":"8451-8459","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-exposure LECS (CLEAN-NET) for gastric cancer: long-term outcomes of a function-preserving strategy with selective nodal assessment"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5368-8377","authenticated-orcid":false,"given":"Manabu","family":"Onimaru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiro","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"issue":"3","key":"13139_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"13139_CR2","unstructured":"Japanese Gastric Cancer Association (2026) Japanese gastric cancer treatment guidelines 2025 (7th edition). Gastric Cancer."},{"issue":"4","key":"13139_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/PL00011720","volume":"3","author":"T Gotoda","year":"2000","unstructured":"Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T et al (2000) Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer 3(4):219\u2013225","journal-title":"Gastric Cancer"},{"key":"13139_CR4","doi-asserted-by":"crossref","unstructured":"Ono H, Yao K, Fujishiro M, Oda I, Uedo N, Nimura S, et al (2021) Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition). Dig Endosc. 33(1):4\u201320","DOI":"10.1111\/den.13883"},{"issue":"6","key":"13139_CR5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1055\/a-1811-7025","volume":"54","author":"P Pimentel-Nunes","year":"2022","unstructured":"Pimentel-Nunes P, Lib\u00e2nio D, Bastiaansen BAJ, Bhandari P, Bisschops R, Bourke MJ et al (2022) Endoscopic submucosal dissection for superficial gastrointestinal lesions: European society of gastrointestinal endoscopy (ESGE) guideline - update 2022. Endoscopy 54(6):591\u2013622","journal-title":"Endoscopy"},{"issue":"12","key":"13139_CR6","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1056\/NEJM199903253401202","volume":"340","author":"JJ Bonenkamp","year":"1999","unstructured":"Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ, Welvaart K, Songun I et al (1999) Extended lymph-node dissection for gastric cancer. N Engl J Med 340(12):908\u2013914","journal-title":"N Engl J Med"},{"issue":"5","key":"13139_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S1470-2045(10)70070-X","volume":"11","author":"I Songun","year":"2010","unstructured":"Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ (2010) Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 11(5):439\u2013449","journal-title":"Lancet Oncol"},{"issue":"7","key":"13139_CR8","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1007\/s00464-007-9696-8","volume":"22","author":"N Hiki","year":"2008","unstructured":"Hiki N, Yamamoto Y, Fukunaga T, Yamaguchi T, Nunobe S, Tokunaga M et al (2008) Laparoscopic and endoscopic cooperative surgery for gastrointestinal stromal tumor dissection. Surg Endosc 22(7):1729\u20131735","journal-title":"Surg Endosc"},{"issue":"2","key":"13139_CR9","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.gie.2017.08.036","volume":"87","author":"O Goto","year":"2018","unstructured":"Goto O, Shimoda M, Sasaki M, Kiguchi Y, Mitsunaga Y, Akimoto T et al (2018) Potential for peritoneal cancer cell seeding in endoscopic full-thickness resection for early gastric cancer. Gastrointest Endosc 87(2):450\u2013456","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"13139_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.soc.2011.09.012","volume":"21","author":"H Inoue","year":"2012","unstructured":"Inoue H, Ikeda H, Hosoya T, Yoshida A, Onimaru M, Suzuki M et al (2012) Endoscopic mucosal resection, endoscopic submucosal dissection, and beyond: full-layer resection for gastric cancer with nonexposure technique (CLEAN-NET). Surg Oncol Clin N Am 21(1):129\u2013140","journal-title":"Surg Oncol Clin N Am"},{"issue":"20","key":"13139_CR11","doi-asserted-by":"publisher","first-page":"582","DOI":"10.21037\/atm.2019.09.19","volume":"7","author":"M Onimaru","year":"2019","unstructured":"Onimaru M, Inoue H, Ikeda H, Abad MRA, Quarta Colosso BM, Shimamura Y et al (2019) Combination of laparoscopic and endoscopic approaches for neoplasia with non-exposure technique (CLEAN-NET) for gastric submucosal tumors: updated advantages and limitations. Ann Transl Med 7(20):582","journal-title":"Ann Transl Med"},{"issue":"5","key":"13139_CR12","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ags3.12787","volume":"8","author":"Y Hashimoto","year":"2024","unstructured":"Hashimoto Y, Abe N, Nunobe S, Kawakubo H, Sumiyoshi T, Yoshida N et al (2024) Outcomes of laparoscopic and endoscopic cooperative surgery for gastric submucosal tumors: a retrospective multicenter study at 21 Japanese institutions. Ann Gastroenterol Surg 8(5):778\u2013786","journal-title":"Ann Gastroenterol Surg"},{"issue":"3","key":"13139_CR13","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s10120-012-0146-5","volume":"15","author":"S Nunobe","year":"2012","unstructured":"Nunobe S, Hiki N, Gotoda T, Murao T, Haruma K, Matsumoto H et al (2012) Successful application of laparoscopic and endoscopic cooperative surgery (LECS) for a lateral-spreading mucosal gastric cancer. Gastric Cancer 15(3):338\u2013342","journal-title":"Gastric Cancer"},{"issue":"1","key":"13139_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s40792-021-01325-1","volume":"7","author":"M Washio","year":"2021","unstructured":"Washio M, Hiki N, Hosoda K, Niihara M, Chuman M, Sakuraya M et al (2021) Laparoscopic and endoscopic cooperative surgery for advanced gastric cancer as palliative surgery in elderly patients: a case report. Surg Case Rep 7(1):241","journal-title":"Surg Case Rep"},{"key":"13139_CR15","doi-asserted-by":"crossref","unstructured":"Japanese Gastric Cancer Association (1998) Japanese classification of gastric carcinoma - 2nd English Edition. Gastric Cancer. 1(1):10\u201324.","DOI":"10.1007\/PL00011681"},{"issue":"6","key":"13139_CR16","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/ajg.2017.95","volume":"112","author":"W Hatta","year":"2017","unstructured":"Hatta W, Gotoda T, Oyama T, Kawata N, Takahashi A, Yoshifuku Y et al (2017) A scoring system to stratify curability after endoscopic submucosal dissection for early gastric cancer: \u201ceCura system.\u201d Am J Gastroenterol 112(6):874\u2013881","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"13139_CR17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s10120-017-0769-7","volume":"21","author":"W Hatta","year":"2018","unstructured":"Hatta W, Gotoda T, Oyama T, Kawata N, Takahashi A, Yoshifuku Y et al (2018) Is the eCura system useful for selecting patients who require radical surgery after noncurative endoscopic submucosal dissection for early gastric cancer? A comparative study. Gastric Cancer 21(3):481\u2013489","journal-title":"Gastric Cancer"},{"issue":"9636","key":"13139_CR18","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0140-6736(08)61159-9","volume":"372","author":"K Fukase","year":"2008","unstructured":"Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S et al (2008) Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 372(9636):392\u2013397","journal-title":"Lancet"},{"issue":"6","key":"13139_CR19","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3904\/kjim.2023.184","volume":"38","author":"Y Choe","year":"2023","unstructured":"Choe Y, Park JM, Kim JS, Cho YK, Kim BW, Choi MG (2023) Factors influencing occurrence of metachronous gastric cancer after endoscopic resection: a systematic review and meta-analysis. Korean J Intern Med 38(6):831\u2013843","journal-title":"Korean J Intern Med"},{"issue":"4","key":"13139_CR20","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1001\/jamaoncol.2018.6727","volume":"5","author":"HH Kim","year":"2019","unstructured":"Kim HH, Han SU, Kim MC, Kim W, Lee HJ, Ryu SW et al (2019) Effect of laparoscopic distal gastrectomy vs open distal gastrectomy on long-term survival among patients with stage I gastric cancer: the KLASS-01 randomized clinical trial. JAMA Oncol 5(4):506\u2013513","journal-title":"JAMA Oncol"},{"issue":"2","key":"13139_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.21037\/jgo-20-374","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Lei X, Liu Z, Shan F, Ying X, Li Z et al (2021) Short-term outcomes of laparoscopic versus open total gastrectomy after neoadjuvant chemotherapy: a cohort study using the propensity score matching method. J Gastrointest Oncol 12(2):237\u2013248","journal-title":"J Gastrointest Oncol"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-026-13139-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-026-13139-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-026-13139-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:13:34Z","timestamp":1790954014000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-026-13139-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["13139"],"URL":"https:\/\/doi.org\/10.1007\/s00464-026-13139-z","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"19 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Haruhiro Inoue is an advisor to Olympus Corporation and Top Corporation. Dr. Manabu Onimaru, Dr. Kenta Nakahara, Dr. Koji Otsuka, Dr. Yoshio Deguchi, and Dr. Noboru Yokoyama declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}}]}}